Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X
Genes · 2023
DOI: 10.3390/genes14020265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Qizong Lao und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health Clinical Center, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program at the National Institutes of Health (NIH).
Abstract (Originalsprache)
CAH-X is a hypermobility-type Ehlers–Danlos syndrome connective tissue dysplasia affecting approximately 15% of patients with 21-hydroxylase deficiency (21-OHD) congenital adrenal hyperplasia (CAH) due to contiguous deletion of CYP21A2 and TNXB genes. The two most common genetic causes of CAH-X are CYP21A1P-TNXA/TNXB chimeras with pseudogene TNXA substitution for TNXB exons 35–44 (CAH-X CH-1) and TNXB exons 40–44 (CAH-X CH-2). A total of 45 subjects (40 families) from a cohort of 278 subjects (135 families of 21-OHD and 11 families of other conditions) were found to have excessive TNXB exon 40 copy number as measured by digital PCR. Here, we report that 42 subjects (37 families) had at least one copy of a TNXA variant allele carrying a TNXB exon 40 sequence, whose overall allele frequency was 10.3% (48/467). Most of the TNXA variant alleles were in cis with either a normal (22/48) or an In2G (12/48) CYP21A2 allele. There is potential interference with CAH-X molecular genetic testing based on copy number assessment, such as with digital PCR and multiplex ligation-dependent probe amplification, since this TNXA variant allele might mask a real copy number loss in TNXB exon 40. This interference most likely happens amongst genotypes of CAH-X CH-2 with an in trans normal or In2G CYP21A2 allele.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Megan Parker, Fabio R Faucz
Förderung
- Intramural Research Program at the National Institutes of Health (NIH)
Zitieren
APA
Lao, Q., Zhou, K., Parker, M., Faucz, F. R., & Merke, D. P. (2023). Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X. Genes. https://doi.org/10.3390/genes14020265
Vancouver
Lao Q, Zhou K, Parker M, Faucz FR, Merke DP. Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X. Genes. 2023. doi:10.3390/genes14020265
BibTeX
@article{Lao2023,
author = {Lao, Qizong and Zhou, Kiet and Parker, Megan and Faucz, Fabio R and Merke, Deborah P},
title = {Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14020265}
}
EUVIMED